Year To Quarter End Statement Of Income

K Pharma,Inc. - Filing #7337586

Concept 2024-01-01 to
2024-03-31
Year to quarter end statement of income
Statement of income
Selling, general and administrative expenses
230,785,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-230,785,000 JPY
Non-operating income
Interest income
14,000 JPY
Non-operating income
14,000 JPY
Ordinary profit (loss)
-230,771,000 JPY
Extraordinary losses
Impairment losses
2,097,000 JPY
Extraordinary losses
2,097,000 JPY
Profit (loss) before income taxes
-232,868,000 JPY
Income taxes - current
579,000 JPY
Income taxes
579,000 JPY
Profit (loss)
-233,448,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.